Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis

Menopause

Volumn 21, Issue 9, 2014, Pages 1007-1016

  Li, Guan Wu ^a   Xu, Zheng ^b   Chang, Shi Xin ^a   Nian, Hua ^a   Wang, Xiao Yan ^a   Qin, Lin Di ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b XinZhuang Community Health Service Center   (China)

Author keywords

Bone mineral density; Icariin; Marrow adiposity; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; ESTRADIOL; ICARIIN; FLAVONOID; HERBACEOUS AGENT;

ADIPOCYTE; ADIPOGENESIS; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW; CELL DENSITY; CELL VOLUME; CONTROLLED STUDY; FAT CONTENT; FEMALE; HISTOPATHOLOGY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OVARIECTOMY-INDUCED OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; QUANTITATIVE ANALYSIS; RAT; ANIMAL; DRUG EFFECTS; HUMAN; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PATHOLOGY; PHOTON ABSORPTIOMETRY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ABSORPTIOMETRY, PHOTON; ADIPOGENESIS; ANIMALS; BONE DENSITY; BONE MARROW; DRUGS, CHINESE HERBAL; FEMALE; FLAVONOIDS; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84906933880     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000201     Document Type: Article

References (52)

1. Mazziotti G, Bilezikian J, Canalis E, Cocchi D, Giustina A. New understanding and treatments for osteoporosis. Endocrine 2012;41:58-69.
2. Li GW, Chang SX, Xu Z, Chen Y, Bao H, Shi X. Prediction of hip osteoporotic fractures from composite indices of femoral neck strength. Skelet Radiol 2013;42:195-201.
3. Seeman E. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 2003; 14(suppl 3):S2-S8.
4. Imai K, Yamamoto S, Anamizu Y, Horiuchi T. Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy. J Bone Miner Metab 2007;25:333-336.
5. Otto S, Schreyer C, Hafner S, et al. Bisphosphonate-related osteonecrosis of the jaws-characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 2012; 40:303-309.
6. Yoon RS, Hwang JS, Beebe KS. Long-term bisphosphonate usage and subtrochanteric insufficiency fractures: a cause for concern. J Bone Joint Surg Br 2011;93:1289-1295.
7. Khedgikar V, Gautam J, Kushwaha P, et al. A standardized phytopreparation from an Indian medicinal plant (Dalbergia sissoo) has antiresorptive and bone-forming effects on a postmenopausal osteoporosis model of rat. Menopause 2012;19:1336-1346.
8. Nian H, Ma MH, Nian SS, Xu LL. Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 2009;16:320-326.
9. Tyagi AM, Srivastava K, Singh AK, et al. Formononetin reverses established osteopenia in adult ovariectomized rats. Menopause 2012;19: 856-863.
10. Hsieh TP, Sheu SY, Sun JS, Chen MH. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. Phytomedicine 2011;18:176-185.
11. Huang J, Yuan L, Wang X, Zhang TL, Wang K. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci 2007;81:832-840.
12. Patsch JM, Li X, Baum T, et al. Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures. J Bone Miner Res 2013;28:1721-1728.
13. Grey A, Beckley V, Doyle A, et al. Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial. Eur J Endocrinol 2012;166:1087-1091.
14. Fazeli PK, Bredella MA, Freedman L, et al. Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa. J Bone Miner Res 2012;27:1864-1871.
15. Beck GR Jr, Khazai NB, Bouloux GF, et al. The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes. Transl Res 2013;161:145-155.
16. Li GW, Xu Z, Chen QW, Chang SX, Tian YN, Fan JZ. The temporal characterization of marrow lipids and adipocytes in a rabbit model of glucocorticoid-induced osteoporosis. Skelet Radiol 2013;42:1235-1244.
17. Chen KM, Ma HP, Ge BF, et al. Icariin enhances the osteogenic differentiation of bone marrow stromal cells but has no effects on the differentiation of newborn calvarial osteoblasts of rats. Pharmazie 2007;62: 785-789.
18. Sheng H, Rui XF, Sheng CJ, et al. A novel semisynthetic molecule icaritin stimulates osteogenic differentiation and inhibits adipogenesis of mesenchymal stem cells. Int J Med Sci 2013;10:782-789.
19. Abdel-Sater KA, Mansour H. Bone biomarkers of ovariectomised rats after leptin therapy. Bratisl Lek Listy 2013;114:303-307.
20. Zhao X, Wu ZX, Zhang Y, et al. Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats. J Ethnopharmacol 2011;137:1083-1088.
21. Ke HZ, Chen HK, Simmons HA, et al. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 1997;20:31-39.
22. Zhang R, Hu SJ, Li C, Zhang F, Gan HQ, Mei QB. Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats. J Ethnopharmacol 2012;139:12-18.
23. Zhang Z, Dong J, Liu M, et al. Therapeutic effects of Cortex acanthopanacis aqueous extract on bone metabolism of ovariectomized rats. Evid Based Complement Altern Med 2012;2012:492627.
24. Shen V, Dempster DW, Birchman R, Xu R, Lindsay R. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 1993;91:2479-2487.
25. Govindarajan P, Schlewitz G, Schliefke N, et al. Implications of combined ovariectomy/multi-deficiency diet on rat bone with age-related variation in bone parameters and bone loss at multiple skeletal sites by DEXA. Med Sci Monit Basic Res 2013;19:76-86.
26. Heiss C, Govindarajan P, Schlewitz G, et al. Induction of osteoporosis with its influence on osteoporotic determinants and their interrelationships in rats by DEXA. Med Sci Monit 2012;18:BR199-BR207.
27. Li GW, Xu Z, Chen QW, et al. Quantitative evaluation of vertebral marrow adipose tissue in postmenopausal female using MRI chemical shift-based water-fat separation [published online ahead of print November 25, 2013]. Clin Radiol. doi: 10.1016/j.crad.2013.10.005.
28. 1-weighted magnetic resonance imaging, modified Dixon method, and magnetic resonance spectroscopy in measuring bone marrow fat. J Obes 2013;2013:298675.
29. Naylor K, Eastell R. Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol 2012;8:379-389.
30. Nishizawa Y, Ohta H, Miura M, et al. Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition). J Bone Miner Metab 2013;31:1-15.
31. Cohen A, Dempster DW, Stein EM, et al. Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2012;97:2782-2791.
32. Ferretti M, Bertoni L, Cavani F, et al. Structural and histomorphometric evaluations of ferutinin effects on the uterus of ovariectomized rats during osteoporosis treatment. Life Sci 2012;90:161-168.
33. Yoon KH, Cho DC, Yu SH, Kim KT, Jeon Y, Sung JK. The change of bone metabolism in ovariectomized rats: analyses of microCT scan and biochemical markers of bone turnover. J Korean Neurosurg Soc 2012; 51:323-327.
34. Schilling T, Ebert R, Raaijmakers N, Schutze N, Jakob F. Effects of phytoestrogens and other plant-derived compounds on mesenchymal stem cells, bone maintenance and regeneration. J Steroid Biochem Mol Biol 2014;139:252-261.
35. Ferretti M, Bertoni L, Cavani F, et al. Influence of ferutinin on bone metabolism in ovariectomized rats, 2: role in recovering osteoporosis. J Anat 2010;217:48-56.
36. Shin YH, Cho DC, Yu SH, Kim KT, Cho HJ, Sung JK. Histomorphometric analysis of the spine and femur in ovariectomized rats using micro-computed tomographic scan. J Korean Neurosurg Soc 2012;52:1-6.
37. Griffith JF, Genant HK. New advances in imaging osteoporosis and its complications. Endocrine 2012;42:39-51.
38. Li GW, Tang GY, Liu Y, Tang RB, Peng YF, Li W. MR spectroscopy and micro-CT in evaluation of osteoporosis model in rabbits: comparison with histopathology. Eur Radiol 2012;22:923-929.
39. Duque G. Bone and fat connection in aging bone. Curr Opin Rheumatol 2008;20:429-434.
40. Jeong S, Yoon M. 17β-Estradiol inhibition of PPARγ-induced adipogenesis and adipocyte-specific gene expression. Acta Pharmacol Sin 2011;32:230-238.
41. Hong L, Zhang G, Sultana H, Yu Y, Wei Z. The effects of 17-β estradiol on enhancing proliferation of human bone marrow mesenchymal stromal cells in vitro. Stem Cells Dev 2011;20:925-931.
42. Elbaz A, Rivas D, Duque G. Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice. Biogerontology 2009; 10:747-755.
43. Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int 2008;19:1323-1330.
44. Somjen D, Katzburg S, Kohen F, et al. The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow. J Endocrinol Invest 2011;34: 106-110.
45. Duque G, Li W, Vidal C, Bermeo S, Rivas D, Henderson J. Pharmacological inhibition of PPARγ increases osteoblastogenesis and bone mass in male C57BL/6 mice. J Bone Miner Res 2013;28:639-648.
46. Duque G, Li W, Adams M, Xu S, Phipps R. Effects of risedronate on bone marrow adipocytes in postmenopausal women. Osteoporos Int 2011;22:1547-1553.
47. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone. Nat Clin Pract Rheumatol 2006;2:35-43.
48. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009;460:259-263.
49. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001;2:165-171.
50. Wehrli FW, Hopkins JA, Hwang SN, Song HK, Snyder PJ, Haddad JG. Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry. Radiology 2000;217:527-538.
51. Schwartz AV, Sigurdsson S, Hue TF, et al. Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults. J Clin Endocrinol Metab 2013;98:2294-2300.
52. Elbaz A, Wu X, Rivas D, Gimble JM, Duque G. Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro. J Cell Mol Med 2010;14:982-991.